ערך בספרים למניה: STAAR Surgical Company (STAA)
STAAR Surgical Company (STAA) specializes in creating high-tech ophthalmological solutions. This chart reflects a price trend with a value of 7.36, based on the sale of unique EVO biocompatible implants for the treatment of myopia. STAAR Surgical Company (STAA) maintains its leadership through the active development of collagen optics and the preparation of presbyopia treatments, consolidating its dominant position in the refractive surgery segment.
פילוחי נתונים אנליטיים מרוכזים עבור staar.com (STAA)
Book value reflects the company's residual capital minus all liabilities, determining the intrinsic value of the business. By analyzing the book value per share, an investor assesses the real growth of net assets excluding market speculation. For STAAR Surgical Company (STAA), this metric is critical during a slowdown in demand for refractive surgery. The stability of this metric confirms financial resilience even amidst regulatory delays. Growth in this indicator guarantees capital protection against fundamental drawdowns.